Literature DB >> 16767921

Electrochemotherapy: a new treatment of solid tumors.

L M Mir1, N Morsli, J R Garbay, V Billard, C Robert, M Marty.   

Abstract

Electrochemotherapy is a new local treatment of the solid tumors that can be defined as the local potentiation, by means of permeabilizing electric pulses, of the antitumor activity of non-permeant (e.g. bleomycin) or low-permeant (e.g. cisplatin) anticancer drugs. The electric pulses are delivered locally on the solid tumors, after the intravenous or intralesional injection of the chemotherapy agent. In this review, the basis of the electrochemotherapy are recalled. Then, after summarizing clinical data, we present some results of the European project Cliniporator, as well as the new pulse generator, the Cliniporator, that incorporates new features resulting from this research project, and that is fully conceived for a clinical use. Finally, future perspectives are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 16767921

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  15 in total

1.  Nanoelectroablation therapy for murine basal cell carcinoma.

Authors:  Richard Nuccitelli; Saleh Sheikh; Kevin Tran; Brian Athos; Mark Kreis; Pamela Nuccitelli; Kris S Chang; Ervin H Epstein; Jean Y Tang
Journal:  Biochem Biophys Res Commun       Date:  2012-07-04       Impact factor: 3.575

2.  Influence of the cell wall on intracellular delivery to algal cells by electroporation and sonication.

Authors:  Harold R Azencott; Gary F Peter; Mark R Prausnitz
Journal:  Ultrasound Med Biol       Date:  2007-06-28       Impact factor: 2.998

3.  Electrochemotherapy treatment of locally advanced and metastatic soft tissue sarcomas: results of a non-comparative phase II study.

Authors:  Luca G Campana; Giuseppe Bianchi; Simone Mocellin; Sara Valpione; Laura Campanacci; Antonella Brunello; Davide Donati; Elisabetta Sieni; Carlo R Rossi
Journal:  World J Surg       Date:  2014-04       Impact factor: 3.352

4.  Nanoscale, electric field-driven water bridges in vacuum gaps and lipid bilayers.

Authors:  Ming-Chak Ho; Zachary A Levine; P Thomas Vernier
Journal:  J Membr Biol       Date:  2013-05-05       Impact factor: 1.843

5.  The Electrorotation as a Tool to Monitor the Dielectric Properties of Spheroid During the Permeabilization.

Authors:  C I Trainito; E Bayart; F Subra; O Français; B Le Pioufle
Journal:  J Membr Biol       Date:  2016-02-26       Impact factor: 1.843

6.  The Effect of Millisecond Pulsed Electric Fields (msPEF) on Intracellular Drug Transport with Negatively Charged Large Nanocarriers Made of Solid Lipid Nanoparticles (SLN): In Vitro Study.

Authors:  Julita Kulbacka; Agata Pucek; Kazimiera Anna Wilk; Magda Dubińska-Magiera; Joanna Rossowska; Marek Kulbacki; Małgorzata Kotulska
Journal:  J Membr Biol       Date:  2016-05-12       Impact factor: 1.843

7.  Electroporation transiently decreases GJB2 (connexin 26) expression in B16/BL6 melanoma cell line.

Authors:  Marcelo Monte Mór Rangel; Lucas Martins Chaible; Marcia Kazumi Nagamine; Gregory Mennecier; Bruno Cogliati; Krishna Duro de Oliveira; Heidge Fukumasu; Idércio Luiz Sinhorini; Lluis Maria Mir; Maria Lúcia Zaidan Dagli
Journal:  J Membr Biol       Date:  2014-10-09       Impact factor: 1.843

8.  Selective field effects on intracellular vacuoles and vesicle membranes with nanosecond electric pulses.

Authors:  Ephrem Tekle; Hammou Oubrahim; Sergey M Dzekunov; Juergen F Kolb; Karl H Schoenbach; P B Chock
Journal:  Biophys J       Date:  2005-04-08       Impact factor: 4.033

9.  Nanoelectroablation of human pancreatic carcinoma in a murine xenograft model without recurrence.

Authors:  Richard Nuccitelli; Joanne Huynh; Kaying Lui; Ryan Wood; Mark Kreis; Brian Athos; Pamela Nuccitelli
Journal:  Int J Cancer       Date:  2012-10-17       Impact factor: 7.396

Review 10.  Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines.

Authors:  Rui Sun; Yuqin Liu
Journal:  Hum Vaccin Immunother       Date:  2013-02-11       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.